North America
China's Up Fintech trades up after $104m US IPO
Up Fintech, an online brokerage firm focused on global Chinese investors that operates in Asia as Tiger Brokers, gained more than 36% in its first day of trading on NASDAQ after raising $104 million in its IPO.
TPG terminates Bill McGlashan amid US bribery scandal
TPG Capital has terminated Bill McGlashan (pictured), founder of its mid-market investment platform TPG Growth and co-founder of impact investment vehicle The Rise Fund, after he was charged this week for his role in the college bribery scandal in the...
Hony co-leads $700m round for US-based STX
Hony Capital has co-led a $700 million funding round for US film and TV studio STX Entertainment along with TPG Growth, the mid-market investment platform of TPG Capital.
Development finance: The great game
As the US overhauls its development finance institution in response to China’s growing infrastructure investment, the PE industry is preparing for a world in which politics goes hand-in-hand with capital
VC-backed Chinese online brokerage files for US listing
Chinese online brokerage Tiger Brokers, which is backed by smart phone maker Xiaomi and a number of venture capital firms, has filed for an IPO in the US.
Chinese self-driving truck player TuSimple raises $95m Series D
TuSimple, a China and US-based developer of autonomous driving technology for trucks, has closed its Series D round at $95 million, achieving a pre-money valuation of $1 billion.
Deal focus: From space food to sustainable food
Sustainable Bioproducts left stealth mode to raise a $33 million Series A round as it targets commercialization for an edible protein technology that won early backing from NASA
1955 Capital leads Series A for sustainable foods specialist
1955 Capital, a cross-border PE firm that invests in US and European technologies with application potential in Asia, has led a $33 million Series A round for edible protein developer Sustainable Bioproducts.
Deal focus: Advent sees potential in hybrid CRO
Advent International recognized BioDuro as a company uniquely positioned to leverage growth in pharmaceutical R&D outsourcing in China and the US
Korean beauty products player gets $35m Series D
JJDC, an investment arm of healthcare and consumer goods giant Johnson & Johnson, has led a $35 million Series D round for South Korean online beauty products retailer Memebox.
LP interview: PennSERS
Bryan Lewis, CIO of Pennsylvania State Employees’ Retirement System, discusses accessing Asia, approaches to co-investment, and paring a bloated PE portfolio into a smaller set of strategic relationships
Apax invests $200m in India, US-based Fractal Analytics
Apax Partners has agreed to pay $200 million for a significant minority stake in India and US-based data analytics provider Fractal Analytics.
Baring Asia, Onex to list Clarivate through reverse merger
Baring Private Equity Asia will list Clarivate Analytics – an education business it acquired from Thomson Reuters in conjunction with Onex Corporation – through a merger with a special purpose investment vehicle that trades in New York.
US, China-based Apollomics raises $100m Series B
CMB International Capital, a private equity unit of China Merchants Bank, has led a $100 million Series B round for US and China-based biopharmaceutical developer Apollomics.
SunBridge exits Marketo's Japan JV to Adobe
SunBridge Partners, a US-based VC firm that helps companies access Japan, has exited its position in a Japanese joint venture (JV) with B2B cloud technology provider Marketo to Adobe.
Q&A: Bain Capital's Jonathan Lavine
Asia’s private credit markets are underdeveloped given the size of the regional economy. Jonathan Lavine, co-managing partner of Bain Capital and CIO of Bain Capital Credit, assesses the growth potential
Q&A: Impossible Foods' Nick Halla
Nick Halla became the first employee at Impossible Foods in 2011. Now leading the rollout of the PE-backed company’s plant-based meat substitute products, he explains the strategy for Asia
ChrysCapital acquires US health-tech player
Indian private equity firm ChrysCapital has acquired a majority stake in GeBBS Healthcare Solutions, a California-based developer of enterprise technology for the healthcare sector.
Family offices: Character actors
Family offices are driven by personalities and ideals that cannot be understood as part of an industry pattern. Relationship building is therefore more intimate than transactional
Deal focus: Investors bring new lift to Rocket Lab
Rocket Lab's latest funding round is aimed at helping the New Zealand-founded company grow into new markets and target new business opportunities
Australia's Future Fund leads $140m round for Rocket Lab
Australia’s Future Fund has led a $140 million Series E round for Rocket Lab, a US-based space technology company that operates primarily in New Zealand.
China’s Ucommune gets $200m in Series D round
Chinese co-working space operator Ucommune, formerly named UrWork, has raised $200 million in Series D funding led by All-Stars Investment, with participation from CEC Capital.
Hillhouse co-leads $93m Series B for US biotech firm
Hillhouse Capital and Quan Capital have led a $93 million Series B round for NextCure, a US-based biopharmaceutical company focused on cancer and other diseases.
Q&A: Alaska Permanent Fund Corporation's Yup S. Kim
Yup S. Kim, a senior portfolio manager for private equity and special opportunities, at Alaska Permanent Fund Corporation (APFC) discusses co-investment, accessing Asia, and allocating to permanent capital structures
